Friday, January 20, 2017

DentalEZ® Donates Massive Amount of Equipment, Supplies to Project Chimps Organization

Contribution Will Provide Complete Dental Care Facility for
the Organization’s New Location

Malvern, PA (January 10, 2017) – For its latest philanthropic endeavor, DentalEZ®, a supplier of integrated products and services for dental health professionals worldwide, recently donated a full shipment of dental supplies and equipment to Project Chimps, a rescue organization dedicated to the lifetime sanctuary care of hundreds of captive chimpanzees.

Specifically, the Company donated various dental products, and operatory and utility room equipment to Project Chimps’ new northern Georgia sanctuary including NevinLabs steel cabinets, DentalEZ® delivery units and operatory lights, StarDental® handpieces, and RAMVAC vacuums and compressors. Because of the Company’s generous donation, the new dental facility will now have all components needed for complete and optimal dental care of the rescued animals.

Peter Volk, Territory Sales Manager for DentalEZ is heading the mission along with Southern Region Manager, Chuck Seeger, and Jason Hodkowski, Senior Institutional Sales Manager. The team is currently working with the company to create the dental facility. “It is interesting because as dental professionals our focus is almost always on our human patients,” remarked Volk. “What most people don’t think about is that all of the animals that they only see on Animal Planet or at the zoo need dental care. Once in a captive environment these animals need to receive all of the preventive care that we humans are accustomed to.”

A recent transfer carried out by Project Chimps prompted the charitable donation by DentalEZ, as well as widespread national attention. Nine chimpanzees once used as research animals at the New Iberia Research Center in Louisiana were just relocated to the new Project Chimps refuge, hundreds of miles from their former home in a lab where they were used as subjects in biomedical testing.

Workers with the non-profit organization transported all nine animals and now Project Chimps sanctuary, located in Morganton, Georgia, is their new home, a sprawling preserve where over 200 chimps will eventually roam free. The 236-acre sanctuary is located along a temperate rainforest, with rolling hills and a lush, green landscape. In addition to office buildings, a full veterinary clinic, and an upscale kitchen designed by celebrity chef Rachael Ray, there are currently four "villas" that can house 10-15 chimps each, and one larger group building that can house two groups of 10-15 chimps. 

“It’s a very rewarding feeling to know that we are providing the medical and dental equipment to chimps that, up to this point, have spent most if not all of their lives in a research laboratory,” continued Volk. “As a DentalEZ representative, it is important that we give back not only to the people in our community, but also to those that do not have a voice. It is our calling as dental professionals to make sure that everyone, both human and animal, are treated with the utmost care and respect.”

In 2015, all chimpanzees were designated an endangered species, marking the end of privately funded research on chimpanzees in the US. Chimps are considered the smartest primate and the closest relatives to humans, which is why the New Iberia Research Center in Louisiana has used 220 of them for medical testing.

The opening of the new Project Chimps sanctuary follows a steady shift away from controversial biomedical research on chimpanzees across the country. The National Institutes of Health (NIH) began significantly phasing out its funding of federal research on chimps in 2013, and announced the retirement of its 50 remaining chimpanzees in November 2015.

NIH also ended its research support for chimps but did not own approximately 360 remaining around the US. Now the private institutions that own them, like the New Iberia Research Center, are following suit. However, due to limited space at existing sanctuaries such as Chimp Haven in Louisiana and Save the Chimps in Florida, the creation of new refuges like Project Chimps is crucial. 

For more information about Project Chimps, please visit

For more information about the DentalEZ company and its complete offerings of dental product and equipment solutions, please visit

About Project Chimps

Project Chimps was founded in late 2014 by a “super group” of chimpanzee, nonprofit, philanthropic, and legal experts to solve the critical question of what would happen to the hundreds of chimps still left in private biomedical research. Primatologists and professionals from all over the country left their current roles and signed on to work for Project Chimps, a nonprofit organization that is making unprecedented advances for captive chimpanzees. Through relationship-building, collaboration, and tenacity, Project Chimps was able to come to an agreement with the University of Louisiana’s New Iberia Research Center. They agreed to let Project Chimps have all of their remaining chimpanzees and provide them with lifetime sanctuary care. This decision is unprecedented and shows what positive collaboration can do for the betterment of others, in this case: chimpanzees. For more information, please visit

About DentalEZ®

DentalEZ Integrated Solutions is committed to providing real solutions to everyday challenges in oral healthcare by uniquely combining innovation focused on simplification and efficiency in value based products and outstanding customer service and support. DentalEZ manufactures a full line of products and well-known brands including StarDental® Instruments, DentalEZ® Equipment, RAMVAC Utility, NevinLabs™ Workstations and Columbia Dentoform® Teaching Solutions. For more information, please visit

# # #

Thursday, January 19, 2017


The 2017 schedule for the Center for Esthetic Excellence features six new courses and nine top clinicians
for an incredible year of learning, fun and comradery at the popular CEEin Chicago. The faculty this year
features three presenters new to the CEE: Dr. Dipesh Parmar, Dr. Matt Costa and Dr. Danièle Larose.
Returning faculty include Dr. Jason Smithson, Dr. Buddy Mopper, Dr.Newton Fahl, Dr. Corky Willhite, Dr.Dennis Hartlieb and Dr. Brian LeSage. 
These small hands-on courses with top clinicians will take your dentistry to a new level.
For information, contact Erika at 800-837-2321

Wednesday, January 18, 2017

OraVital’s 2017 KOL Access Webinar Series

Dr. Bradley Bale & Dr. Amy Doneen Kick-Off
OraVital’s 2017 KOL Access Webinar Series

The Presenters Will Review the Findings of Their British Medical Journal Paper That Shows High Risk Periodontal Pathogens
are a Contributory Cause of Arterial Disease

Toronto, CA – January 10, 2017 – OraVital Inc., The Oral Infection Experts™, will be kicking off its 2017 KOL Access Webinar Series, with two of the leading pioneers of the oral-systemic health movement; Dr. Bradley Bale and Dr. Amy Doneen, who are the authors of the best-selling book, “Beat the Heart Attack Gene”

Long time advocates of the critical role that dental professionals play in the prevention of heart attacks and strokes, Drs. Bale and Doneen recently co-authored an article with Dr. David Vigerust that will be published in print in the prestigious Postgraduate Medical Journal and was published online ahead of print by the British Medical Journal (BMJ) entitled, “High-Risk Periodontal Pathogens Contribute to the Pathogenesis of Atherosclerosis.”

According to OraVital CEO, Dr. Jim Hyland, “This is a ground-breaking report that further validates the oral-systemic health link in general and more specifically, the perio-cardio link. The PGMJ /BMJ manuscript clearly states, ‘periodontal disease due to high risk pathogens is a cause of arterial disease.’ Now more than ever, dental clinicians can and should strengthen their commitment identifying and managing this form of periodontal disease.”  

Because of the complexity of the topic and because atherosclerosis is the largest cause of death and disability in North America, Drs. Bale and Doneen have been invited to present their findings in a two-part CE webinar. The schedule is as follows:
·       Thursday, 2/9/17 l 8:30 PM EST: “High-Risk Periodontal Pathogens Contribute to the Pathogenesis of Atherosclerosis.” l Presented by Bradley Field Bale, M.D. l 1 CEU
According to Dr. Bale, “Periodontal disease due to high risk pathogens must be considered a contributory cause of arterial disease.  Dr. Bale will present the science which supports this landmark statement.  Considering this knowledge, the dental community has a significant opportunity to favorably impact the number one cause of death and disability by effectively managing this type of periodontal disease.”
·       Thursday, 3/9/17 l 8:30 PM EST: “Integrating the Science of Oral/Systemic Health into Clinical Practice.” l Presented by Amy Doneen, DNP, ARNP l 1 CEU

“It is necessary to respect the clinical context for which the information outlined in the recent BMJ study can be applied to the clinical dental arena,” explained Dr. Doneen. “What’s more, lines of communication must be created between medicine and dentistry that can clearly articulate the importance of understanding the oral pathogen burden as it relates to the vascular health of the individual patient.”  

For more information on the 2017 KOL Access Webinar Series, sponsored by OraVital® and how to register for each upcoming webinar, visit Dental industry thought leaders wishing to participate in future KOL Access Webinars are invited to send an abstract to
About Bradley Bale, MD:  Dr. Bale is an Adjunct Professor at Texas Tech Health Science Center, Medical Director of the Heart Health Program at Grace Clinic, Lubbock, Texas and Co-founder of The Bale/Doneen Method.  This precision healthcare system has been shown to halt, stabilize and regress arterial disease. 

About Amy L. Doneen, DNP, ARNP:  Dr. Doneen co-founded the Bale/Doneen Method, which ensures arterial wellness.  She is medical director of The Heart Attack & Stroke Prevention Center and adjunct professor at Texas Tech Health Sciences.  Dr. Doneen is a national thought-leader and co-author of the bestselling book, Beat the Heart Attack Gene.  

About OraVital Inc.

Headquartered in Toronto, Canada, OraVital Inc., is the developer of the comprehensive OraVital® System, which provides the most accurate diagnosis and effective treatment of the oral infections that cause periodontal disease, halitosis, peri-implantitis and caries. Consisting of a proprietary protocol of advanced microbiology tests BioFilmDNA™ and BioFilmGS™ (Gram stain), combined with a personalized regimen of prescribed antibiotic/antifungal and antimicrobial rinses, the OraVital® System controls 90% of periodontal disease, halitosis, peri-implantitis and caries in just 4 weeks when used as directed. For more information, visit

# # #

Tuesday, January 17, 2017

Evaluation of pit-and-fissure sealants placed with four different bonding protocols: a randomized clinical trial





    Application of adhesive after acid etching may increase the retention of pit-and-fissure sealants and improve clinical effectiveness.


    To clinically evaluate the retention, marginal discoloration and caries incidence of pit-and-fissure sealants applied using four bonding protocols: conventional acid etching, etch-and-rinse adhesive, multimode universal adhesive and self-etch adhesive used after acid etching.


    In this split-mouth design study, the four adhesive protocols were randomly assigned to the four erupted, non-carious first permanent molars and involved 52 patients between 6 and 10 years of age. The sealants were evaluated at 3-, 6- and 12-month intervals. Statistical analysis was carried out using Friedman test and Kruskal–Wallis test.


    At 12 months, the retention rate was maximum in etch-and-rinse and universal adhesive groups (77.1%) followed by self-etch adhesive (58.3%) and conventional acid etching group (45.8%). Dental caries was observed only in one tooth, and marginal discoloration was found to be the highest in conventional group and least in etch-and-rinse group.


    Use of adhesives during pit-and-fissure sealant application does not significantly enhance sealant retention nor decrease marginal discoloration. Etch-and-rinse adhesive is advantageous only at short term.

    Monday, January 16, 2017

    The evaluation of trustworthiness to identify health insurance fraud in dentistry

    Available online 27 December 2016


    The Economist says 10% of health care expenditure ($272 billion) was wasted on fraudulent claims in 2012.
    Previous studies aimed at other types of fraud are inadequate for solving cross-dentist health insurance fraud.
    We devise a social-network-based risk evaluation to detect fraudulent claims in dentistry.
    By experiment, using real-world or artificial data, our method can effectively identify undetected frauds in the past in dentistry claims data.
    Integrating our method with previous research can provide higher accuracy.



    According to the investigations of the U.S. Government Accountability Office (GAO), health insurance fraud has caused an enormous pecuniary loss in the U.S. In Taiwan, in dentistry the problem is getting worse if dentists (authorized entities) file fraudulent claims. Several methods have been developed to solve health insurance fraud; however, these methods are like a rule-based mechanism. Without exploring the behavior patterns, these methods are time-consuming and ineffective; in addition, they are inadequate for managing the fraudulent dentists.


    Based on social network theory, we develop an evaluation approach to solve the problem of cross-dentist fraud. The trustworthiness score of a dentist is calculated based upon the amount and type of dental operations performed on the same patient and the same tooth by that dentist and other dentists.


    The simulation provides the following evidence. (1) This specific type of fraud can be identified effectively using our evaluation approach. (2) A retrospective study for the claims is also performed. (3) The proposed method is effective in identifying the fraudulent dentists.


    We provide a new direction for investigating the genuineness of claims data. If the insurer can detect fraudulent dentists using the traditional method and the proposed method simultaneously, the detection will be more transparent and ultimately reduce the losses caused by fraudulent claims.

    Friday, January 13, 2017

    Adjunctive efficacy of probiotics in the treatment of experimental peri-implant-mucositis with mechanical and photodynamic therapy: a randomized, cross-over clinical trial.

    J Clin Periodontol. 2016 Dec 29. doi: 10.1111/jcpe.12689. [Epub ahead of print]



    to evaluate the adjunctive clinical efficacy of probiotics in the treatment of peri-implant mucositis (p-iM) with professionally administered plaque removal (PAPR) and photodynamic therapy (PDT).


    Following p-iM induction, patients underwent PAPR+PDT and were randomly assigned to receive the professional and home-based administration of probiotics (Lactobacillus plantarum and Lactobacillus brevis) (test treatment) or placebo preparation (control treatment) according to a cross-over design. Clinical parameters were assessed at 6 sites for each implant before as well as at 2 and 6 weeks after professional treatment administration.


    Twenty patients contributing 1 dental implant each were included. Immediately before treatment and at 6 weeks, the median number of sites with bleeding on probing (BoP+) sites per implant unit was 4 (3-6) and 2 (0-2) (p< 0.001), respectively, for test treatment, and 3.5 (2-4) and 2 (0-3) (p= 0.03), respectively, for control treatment. No significant difference in clinical outcomes was observed between treatment groups.

    CONCLUSION: The combination of PAPR and PDT either alone or associated with probiotics determined a significant reduction of the number of BoP+ sites at 2 and 6 weeks around implants with p-iM. The adjunctive use of probiotics did not significantly enhance the clinical outcomes of PAPR + PDT.

    Thursday, January 12, 2017

    Treatment Outcomes of Mineral Trioxide Aggregate Pulpotomy in Vital Permanent Teeth with Carious Pulp Exposure: The Retrospective Study

    Journal of Endodontics




    This study aimed to illustrate the treatment outcomes of mineral trioxide aggregate (MTA) pulpotomy in vital permanent teeth with carious pulp exposure.


    MTA pulpotomy was performed in 66 vital permanent teeth with carious pulp exposure including teeth with signs and symptoms of irreversible pulpitis and the presence of periapical radiolucency. Patients were assessed for clinical and radiographic outcomes by 2 examiners. The relationship between treatment outcomes and factors was analyzed by means of univariate analysis and binary logistic regression.


    Fifty patients (a total of 55 teeth) attended the follow-up examination. The age of the patients ranged from 7–68 years old (mean = 29 years old). For the follow-up period as far as 62 months, 48 teeth showed successful outcomes (success rate = 87.3%). Teeth with clinical signs of irreversible pulpitis and the presence of periapical radiolucency could be treated successfully by MTA pulpotomy with success rates of 84% and 76%, respectively.Three of 7 failed cases required pulpectomy after MTA pulpotomy to relieve painful pulpitis. Four other failed cases were asymptomatic, and failure was detected from radiographic examination. The relationship between treatment outcomes and treatment factors could not be detected statistically.


    Teeth with carious pulp exposure can be treated successfully by MTA pulpotomy. Clinical signs of irreversible pulpitis and the presence of periapical radiolucency should not be considered as a contraindication for pulpotomy.